Home » Spectrum Pharma Closes RIT Oncology Acquisition
Spectrum Pharma Closes RIT Oncology Acquisition
Spectrum Pharmaceuticals, Inc. said it closed the acquisition of RIT Oncology LLC by making the final payment of the $18 million deal to its former partner Cell Therapeutics, Inc.
RTTNews
RTTNews
Upcoming Events
-
28Mar
-
04Apr
-
11Apr
-
14Apr
-
25Apr
-
14May